BI-671800, G 蛋白偶联受体 44 拮抗剂

前列腺素受体拮抗剂
  • 10mM in DMSO
有货

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
B420563-1ml
1ml 现货 Stock Image

基本描述

英文别名 NCGC00345797-02 | AC-30903 | Actimis | BI671800 | BI-671800 | 5-Pyrimidineacetic acid, 4,6-bis(dimethylamino)-2-((4-((4-(trifluoromethyl)benzoyl)amino)phenyl)methyl)- | 2-(4,6-bis(dimethylamino)-2-(4-(4-(trifluoromethyl)benzamido)benzyl)pyrimidin-5-yl)ace
规格或纯度 10mM in DMSO
英文名称 BI-671800
生化机理 BI-671800(AP-761,Cmpd A)是一种高度特异且强效的 Th2 细胞趋化受体同源分子(DP2/CRTH2)拮抗剂,其 PGD2 与人 CRTH2 和鼠 CRTH2 结合的 IC50 分别为 4.5 nM 和 3.7 nM。BI-671800 能小幅改善有症状的控制期哮喘患者和服用 ICS 患者的 FEV1。
储存温度 -80℃储存
运输条件 超低温冰袋运输
作用类型 拮抗剂
作用机制 G 蛋白偶联受体 44 拮抗剂
产品介绍


Information

BI-671800 BI-671800 (AP-761, Cmpd A) is a highly specific and potent antagonist of chemoattractant receptor-homologous molecule on Th2 cells (DP2/CRTH2) with IC50 of 4.5 nM and 3.7 nM for PGD2 binding to human CRTH2 and murine CRTH2, respectively. BI-671800 is associated with a small improvement in FEV1 in symptomatic controller-naïve asthma patients, and in patients on ICS.

Targets

murine CRTH2 (Cell-free assay); human CRTH2 (Cell-free assay) 3.7 nM; 4.5 nM

产品属性

ALogP 4.3

关联靶点(人)

PTGDR2 Tchem 前列腺素 D2 受体 2(Prostaglandin D2 receptor 2) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
PTGIR Tclin Prostanoid IP receptor (1280 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
TBXA2R Tclin Thromboxane A2 receptor (5717 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
PTGDR Tclin Prostanoid DP receptor (1356 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
PTGDR2 Tchem G protein-coupled receptor 44 (4688 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID

关联靶点(其它种属)

Blood (6 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

名称和识别符

分子类型 小分子
IUPAC Name 2-[4,6-bis(dimethylamino)-2-[[4-[[4-(trifluoromethyl)benzoyl]amino]phenyl]methyl]pyrimidin-5-yl]acetic acid
INCHI InChI=1S/C25H26F3N5O3/c1-32(2)22-19(14-21(34)35)23(33(3)4)31-20(30-22)13-15-5-11-18(12-6-15)29-24(36)16-7-9-17(10-8-16)25(26,27)28/h5-12H,13-14H2,1-4H3,(H,29,36)(H,34,35)
InChi Key XEOSTBFUCNZKGS-UHFFFAOYSA-N
Canonical SMILES CN(C)C1=C(C(=NC(=N1)CC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(F)(F)F)N(C)C)CC(=O)O
Isomeric SMILES CN(C)C1=C(C(=NC(=N1)CC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(F)(F)F)N(C)C)CC(=O)O
分子量 501.5
Reaxy-Rn 18799793
Reaxys-RN link address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=18799793&ln=

化学和物理性质

分子量 501.500 g/mol
XLogP3 4.300
氢键供体数Hydrogen Bond Donor Count 2
氢键受体数Hydrogen Bond Acceptor Count 10
可旋转键计数Rotatable Bond Count 8
精确质量Exact Mass 501.199 Da
单同位素质量Monoisotopic Mass 501.199 Da
拓扑极表面积Topological Polar Surface Area 98.700 Ų
重原子数Heavy Atom Count 36
形式电荷Formal Charge 0
复杂度Complexity 717.000
同位素原子数Isotope Atom Count 0
定义的原子立体中心计数Defined Atom Stereocenter Count 0
未定义的原子立体中心计数Undefined Atom Stereocenter Count 0
定义的键立体中心计数Defined Bond Stereocenter Count 0
未定义的键立体中心计数Undefined Bond Stereocenter Count 0
所有立体化学键的总数The total count of all stereochemical bonds 0
共价键合单元计数Covalently-Bonded Unit Count 1

安全和危险性(GHS)

Reaxy-Rn 18799793
Reaxys-RN link address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=18799793&ln=

技术规格说明书

Concentration 9-11(mmol/L)
Proton NMR spectrum Conforms to Structure

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

溶液计算器

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.